Showing results (851-860 of 1,310) with videos related to
Sort By:
Pageof 131
Technology in Cancer Research & Treatment|October 23, 2014
Quantitative Analysis Tools and Digital Phantoms for Deformable Image Registration Quality AssuranceHaksoo Kim, Samuel B Park, James I Monroe, et al.Anticancer Research|August 15, 2001
Tie-1 tyrosine kinase is an independent prognostic indicator for invasive breast cancerL M Tseng, C Y Hsu, H C Wang, et al.Journal of Pediatric Endocrinology & Metabolism : JPEM|May 1, 2001
The promoter region of the CTLA4 gene is associated with type 1 diabetes mellitusY J Lee, F S Lo, S G Shu, et al.Oncotarget|November 22, 2017
Vemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600EZeus A Antonello, Nancy Hsu, Manoj Bhasin, et al.Plos One|July 9, 2021
Development and analytical validation of a novel bioavailable 25-hydroxyvitamin D assayAnders H Berg, Mahtab Tavasoli, Agnes S Lo, et al.Expert Review of Anticancer Therapy|May 18, 2010
Management of metastatic spinal cord compressionKevin Shiue, Arjun Sahgal, Edward Chow, et al.International Journal of Systematic and Evolutionary Microbiology|June 6, 2020
Parapseudoflavitalea muciniphila gen. nov., sp. nov., a member of the family Chitinophagaceae isolated from a human peritoneal tumour and reclassification of Pseudobacter ginsenosidimutans as Pseudoflavitalea ginsenosidimutans comb. novPaul A Lawson, Nisha B Patel, Ahmed Mohammed, et al.HIV Medicine|July 16, 2003
Characterization of viro-immunological responses in a closely followed cohort of heavily pretreated patients: evidence from the GenPheRex StudyC Torti, E Quiros-Roldan, L Scudeller, et al.Molecular Cancer Therapeutics|September 11, 2012
Intratumoral molecular heterogeneity in a BRAF-mutant, BRAF inhibitor-resistant melanoma: a case illustrating the challenges for personalized medicineJames S Wilmott, Varsha Tembe, Julie R Howle, et al.Virology|February 9, 2000
Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in AsiaY J Guo, S Krauss, D A Senne, et al.Pageof 131